Immunoglobulin deficiency in multiple sclerosis - prevalence and association with disease-modifying therapy and disease course

被引：0

作者：

Zoehner, G. ^{[1
]}

Miclea, A. ^{[1
]}

Salmen, A. ^{[1
]}

Kamber, N. ^{[1
]}

Diem, L. ^{[1
]}

Friedli, C. ^{[1
]}

Bagnoud, M. ^{[1
]}

Ahmadi, F. ^{[1
]}

Briner, M. ^{[1
]}

Sedille-Mostafaie, N. ^{[2
]}

Constantinos, K. ^{[3
]}

Leonidas, S. ^{[3
]}

Chan, A. ^{[1
]}

Hoepner, R. ^{[1
]}

Evangelopoulos, M. E. ^{[3
]}

机构：

[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland

[2] Univ Bern, Univ Hosp Bern, Inselspital, Univ Inst Clin Chem, Bern, Switzerland

[3] Univ Athens, Eginit Univ Hosp, Dept Neurol, Athens, Greece

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPR3107

引用

页码：341 / 341

页数：1

共 50 条

[1] Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
Zoehner, Greta
Miclea, Andrei
Salmen, Anke
Kamber, Nicole
Diem, Lara
Friedli, Christoph
Bagnoud, Maud
Ahmadi, Farhad
Briner, Myriam
Sedille-Mostafaie, Nazanin
Kilidireas, Constantinos
Stefanis, Leonidas
Chan, Andrew
Hoepner, Robert
Evangelopoulos, Maria Eleftheria
[J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12
[2] Disease-modifying therapy for multiple sclerosis
Holmoy, Trygve
Myhr, Kjell-Morten
Bo, Lars
Nygaard, Gro Owren
[J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (08) : 723 - 726
[3] Disease-modifying therapy for multiple sclerosis
Klineova, Sylvia
Mitiku, Nesanet
Miller, Aaron E.
[J]. FUTURE NEUROLOGY, 2015, 10 (03) : 253 - 279
[4] Multiple sclerosis disease-modifying therapy and pregnancy
Miller, Aaron E.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
[5] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
Tanuja Chitnis
[J]. Neurotherapeutics, 2013, 10 : 89 - 96
[6] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
Chitnis, Tanuja
[J]. NEUROTHERAPEUTICS, 2013, 10 (01) : 89 - 96
[7] Multiple sclerosis disease course and immunotherapy are associated with the prevalence of immunoglobulin deficiency
Zoehner, G.
Miclea, A.
Salmen, A.
Kamber, N.
Diem, L.
Friedli, C.
Bagnoud, M.
Ahmadi, F.
Briner, M.
Sedille-Mostafaie, N.
Constantinos, K.
Leonidas, S.
Chan, A.
Hoepner, R.
Evangelopoulos, M. E.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 167 - 168
[8] Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
Ng, Huah Shin
Zhu, Feng
Kingwell, Elaine
Yao, Shenzhen
Ekuma, Okechukwu
Evans, Charity
Fisk, John D.
Marrie, Ruth Ann
Zhao, Yinshan
Tremlett, Helen
[J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (05):
[9] Vitamin D as disease-modifying therapy for multiple sclerosis?
Lincoln, Matthew R.
Schneider, Raphael
Oh, Jiwon
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) : 691 - 693
[10] Adherence of Adolescents to Multiple Sclerosis Disease-Modifying Therapy
Thannhauser, Jennifer E.
Mah, Jean K.
Metz, Luanne M.
[J]. PEDIATRIC NEUROLOGY, 2009, 41 (02) : 119 - 123

← 1 2 3 4 5 →